CTLA4 and neoplasm: In mice, localized administration of CD47nb increased the activation of tumor-infiltrating T cells while dramatically inhibiting tumor development [122] In the follow-up study, E. coli Nissle 1917 was engineered with SLC in a subsequent effort to generate nanobodies targeting PD-L1 and CTLA-4.